Combatting Antimicrobial Resistance in Europe: Epidemiology, Innovations, and Interdisciplinary Strategies

Antimicrobial resistance (AMR) has become a critical public health challenge in the 21st century, progressively undermining the effectiveness of infection prevention and treatment. The rapid proliferation of resistant pathogens has been declared an urgent crisis by global health authorities, including the World Health Organization (WHO). Recent advancements in surveillance strategies, such as the 2022 Global Antimicrobial Resistance and Use Surveillance System (GLASS) report and impending 2025 WHO guidelines, aim to standardize methodologies across nations, ensuring clarity and consistency in assessments. Europe, with its dense populations and high mobility, presents unique challenges and opportunities for managing AMR, necessitating a robust and coordinated response from public health systems.This Research Topic aims to explore comprehensive advancements and studies related to AMR, focusing particularly on Europe—a critical hub for emerging AMR trends and interventions. As resistant strains outpace new treatment development, understanding the epidemiological spread and exploring novel therapeutic strategies is more important than ever. Our objective is to compile a multifaceted analysis of AMR, addressing pervasive challenges and significant innovations within the context of public health in Europe. Through interdisciplinary collaborations, we seek to drive scalable solutions that inform effective policies and practices to counteract AMR proliferation.To gather further insights into AMR in Europe, we welcome articles addressing, but not limited to, the following themes:1. Epidemiological trends of AMR in European countries.2. Risk factors for the emergence and spread of AMR in community and healthcare settings.3. Impact and analysis of WHO's GLASS report data specific to Europe.4. Novel surveillance strategies for detecting AMR.5. Innovative treatment protocols, including shorter duration and oral step-down therapies.6. The role of ESKAPE pathogens in the landscape of European antimicrobial resistance.7. Multidisciplinary approaches to improve AMR intervention outcomes.8. Economic analysis of the burden of AMR and cost-effectiveness of interventions.9. Implementation science studies focusing on AMR control measures.10. Policy recommendations based on recent AMR data and trends specific to Europe. Topic editors: Amanda Radulescu, Mihaela Lupse, Antigoni Kotsaki Source: https://www.frontiersin.org/research-topics/72986/combatting-antimicrobial-resistance-in-europe-epidemiology-innovations-and-interdisciplinary-strategies